These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19540583)

  • 1. Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics.
    Kanchan V; Katare YK; Panda AK
    Biomaterials; 2009 Sep; 30(27):4763-76. PubMed ID: 19540583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK; Panda AK
    Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK; Muthukumaran T; Panda AK
    Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.
    Gupta RK; Goswami DG; Singh RR; Surolia A; Panda AK
    Eur J Pharm Sci; 2012 Feb; 45(3):282-95. PubMed ID: 22155747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenic characteristics associated with multivalent display of Vi polysaccharide antigen using biodegradable polymer particles.
    Anish C; Goswami DG; Kanchan V; Mathew S; Panda AK
    Biomaterials; 2012 Oct; 33(28):6843-57. PubMed ID: 22748669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V; Katare YK; Panda AK
    Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine.
    Katare YK; Panda AK; Lalwani K; Haque IU; Ali MM
    Drug Deliv; 2003; 10(4):231-8. PubMed ID: 14612338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
    Katare YK; Panda AK
    Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response.
    Kanchan V; Panda AK
    Biomaterials; 2007 Dec; 28(35):5344-57. PubMed ID: 17825905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid.
    Cruz SC; Silva GP; Sampaio FJ; Souza SL; Dias AA; Milagres LG
    Vaccine; 2010 Oct; 28(42):6841-6. PubMed ID: 20719254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A.
    Anish C; Upadhyay AK; Sehgal D; Panda AK
    Int J Pharm; 2014 May; 466(1-2):198-210. PubMed ID: 24631054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.
    Amidi M; Pellikaan HC; Hirschberg H; de Boer AH; Crommelin DJ; Hennink WE; Kersten G; Jiskoot W
    Vaccine; 2007 Sep; 25(37-38):6818-29. PubMed ID: 17692440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates.
    Fraser CC; Altreuter DH; Ilyinskii P; Pittet L; LaMothe RA; Keegan M; Johnston L; Kishimoto TK
    Vaccine; 2014 May; 32(24):2896-903. PubMed ID: 24583006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
    He Y; Chen ZH; Wei SL
    Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
    Kung FH; Orgel HA; Wallace WW; Hamburger RN
    Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Vaccine; 1998 Feb; 16(4):346-52. PubMed ID: 9607054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.